Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Equity Ratio (2016 - 2025)

Bio Key International's Equity Ratio history spans 16 years, with the latest figure at 0.6 for Q3 2025.

  • For Q3 2025, Equity Ratio rose 2775.28% year-over-year to 0.6; the TTM value through Sep 2025 reached 0.6, up 2775.28%, while the annual FY2024 figure was 0.44, 85.94% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.6 at Bio Key International, down from 0.65 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.91 in Q1 2021 and bottomed at 0.22 in Q2 2024.
  • The 5-year median for Equity Ratio is 0.6 (2025), against an average of 0.49.
  • The largest annual shift saw Equity Ratio plummeted 241.13% in 2024 before it skyrocketed 2775.28% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.88 in 2021, then plummeted by 46.82% to 0.47 in 2022, then tumbled by 49.62% to 0.24 in 2023, then skyrocketed by 85.94% to 0.44 in 2024, then skyrocketed by 36.53% to 0.6 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Equity Ratio are 0.6 (Q3 2025), 0.65 (Q2 2025), and 0.67 (Q1 2025).